Reflex EGFR testing in all early-stage NSCLC at diagnosis or after surgery may be a sustainable approach to give patients the best chance to benefit from targeted adjuvant treatment and prevent disease relapse. Here, EGFR is linked to non-small cell lung carcinoma.